At ASH, optimistic information for Terns, Kura leukemia remedies

Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug improvement, enterprise, Wall Road, and biotechnology. He’s additionally a co-host of the weekly biotech podcast The Readout Loud and creator of the publication Adam’s Biotech Scorecard. You may attain Adam on Sign at stataf.54.

Damian Garde is a reporter at massive, reside and have journalism, masking the worldwide drug {industry} and contributing to STAT’s industry-leading occasions.

That is the net model of ASH in 30 Seconds, STAT’s report from the American Society of Hematology assembly. Join the e-mail model right here.

It rains in Florida. Rather a lot. This ASH assembly began sunny and fantastic, however rapidly turned wet and depressing. It’s simply one more reason why ASH ought to camp itself completely in San Diego every December.

Research suggests Terns leukemia drug might be successor to Novartis blockbuster

Adam Feuerstein/STAT

Terns Prescribed drugs reported an replace on its focused leukemia drug that maintained and even boosted excessive molecular response charges in advanced-stage sufferers.

STAT+ Unique Story

STAT+